Ryan AJ - Search Results

1

Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats.

Bradley DP, Tessier JJ, Ashton SE, Waterton JC, Wilson Z, Worthington PL, Ryan AJ. Bradley DP, et al. Among authors: ryan aj. Neoplasia. 2007 May;9(5):382-91. doi: 10.1593/neo.07145. Neoplasia. 2007. PMID: 17534443 Free PMC article.

2

Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model.

McIntyre DJ, Robinson SP, Howe FA, Griffiths JR, Ryan AJ, Blakey DC, Peers IS, Waterton JC. McIntyre DJ, et al. Among authors: ryan aj. Neoplasia. 2004 Mar-Apr;6(2):150-7. doi: 10.1593/neo.03247. Neoplasia. 2004. PMID: 15140404 Free PMC article.

3

The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy.

Madhu B, Waterton JC, Griffiths JR, Ryan AJ, Robinson SP. Madhu B, et al. Among authors: ryan aj. Neoplasia. 2006 Jul;8(7):560-7. doi: 10.1593/neo.06319. Neoplasia. 2006. PMID: 16867218 Free PMC article.

4

Distribution of radioactivity and metabolite profiling in tumour and plasma following intravenous administration of a colchicine derivative (14C-ZD6126) to tumour-bearing mice.

D'Souza RA, Partridge EA, Roberts DW, Ashton S, Ryan A, Patterson AB, Wilson Z, Thurrell CC. D'Souza RA, et al. Xenobiotica. 2007 Mar;37(3):328-40. doi: 10.1080/00498250601169824. Xenobiotica. 2007. PMID: 17624029

5

Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging.

Robinson SP, McIntyre DJ, Checkley D, Tessier JJ, Howe FA, Griffiths JR, Ashton SE, Ryan AJ, Blakey DC, Waterton JC. Robinson SP, et al. Among authors: ryan aj. Br J Cancer. 2003 May 19;88(10):1592-7. doi: 10.1038/sj.bjc.6600926. Br J Cancer. 2003. PMID: 12771928 Free PMC article.

6

ZD6126: a novel small molecule vascular targeting agent.

Blakey DC, Ashton SE, Westwood FR, Walker M, Ryan AJ. Blakey DC, et al. Among authors: ryan aj. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1497-502. doi: 10.1016/s0360-3016(02)03922-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459377

7

Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.

Robinson SP, Kalber TL, Howe FA, McIntyre DJ, Griffiths JR, Blakey DC, Whittaker L, Ryan AJ, Waterton JC. Robinson SP, et al. Among authors: ryan aj. Neoplasia. 2005 May;7(5):466-74. doi: 10.1593/neo.04622. Neoplasia. 2005. PMID: 15967099 Free PMC article.

8

Effect of pretreatment with atenolol and nifedipine on ZD6126-induced cardiac toxicity in rats.

Gould S, Westwood FR, Curwen JO, Ashton SE, Roberts DW, Lovick SC, Ryan AJ. Gould S, et al. Among authors: ryan aj. J Natl Cancer Inst. 2007 Nov 21;99(22):1724-8. doi: 10.1093/jnci/djm202. Epub 2007 Nov 13. J Natl Cancer Inst. 2007. PMID: 18000220

9

Longitudinal in vivo susceptibility contrast MRI measurements of LS174T colorectal liver metastasis in nude mice.

Kalber TL, Waterton JC, Griffiths JR, Ryan AJ, Robinson SP. Kalber TL, et al. Among authors: ryan aj. J Magn Reson Imaging. 2008 Dec;28(6):1451-8. doi: 10.1002/jmri.21600. J Magn Reson Imaging. 2008. PMID: 19025954

10

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.

Tai JH, Tessier J, Ryan AJ, Hoffman L, Chen X, Lee TY. Tai JH, et al. Among authors: ryan aj. Neoplasia. 2010 Sep;12(9):697-707. doi: 10.1593/neo.10292. Neoplasia. 2010. PMID: 20824046 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters